Combination Products Conference

Featured

Want to learn more about Combination Products Conference? You've come to the right site!

To keep you at the forefront.

Primer:

APPs/Digital Health in Combination Products - QMS and Risk Management Opportunities and Challenges

Primer:

APPs/Digital Health in Combination Products - QMS and Risk Management Opportunities and Challenges

James Wabby, MHS VP, Head of Regulatory Strategy, Emerging Technologies and Combination Products
AbbVie, United States
Karthik Balasubramanian, PhD, MS Dir Project/Program Management, External Manufacturing
Teva Pharmaceuticals, United States
Khaudeja Bano, DrMed, MD, MS Vice President, Combination Product Quality
Genentech, United States
John Weiner, JD Associate Director for Policy, Office of Combination Products, OCPP, OC
FDA, United States
Jonathan Amaya-Hodges Senior Principal Consultant
United States
Chin-Wei Soo, DRSc Global Regulatory Head, PTR Devices and Combination Products
Genentech, A Member of the Roche Group, United States
Demetra Macheras, MBA
United States
Darin Seth Oppenheimer, DRSc Executive Director, Device & Digital Health Solutions
Merck & Co., Inc., United States